Cognitive & Neuroprotective
RG3 + Methylcobalamin + NAD+
Clinic-compounded cognitive stack pairing an 'RG3' component with B12 and NAD+; components vary and the combo is unstudied.
Overview
This is a clinic-style combination rather than a single compound. It pairs methylcobalamin, an active form of vitamin B12 that supports methylation and nerve health, with NAD+, a coenzyme central to mitochondrial energy production and DNA repair that declines with age. The third component, 'RG3', is inconsistently defined: some suppliers mean ginsenoside Rg3, a ginseng saponin with anti-inflammatory and neuroprotective effects in animal studies, while others mean a Selank-related peptide. The rationale is layered support for energy, mood and cognition. Only B12 has strong evidence, and only in people who are deficient. Confirming exactly what 'RG3' is in a given product is essential before use, and NAD+ infusions must be given slowly.
- Classification
- Combination: 'RG3' (ginsenoside Rg3 or a Selank-related peptide, depending on source) + methylcobalamin + NAD+
- Route
- Intravenous (NAD+), intramuscular (methylcobalamin), intranasal or oral (RG3 component)
- Half-life
- Component-dependent (NAD+ IV: short, minutes to hours; methylcobalamin: days)
Mechanism of action
- Methylcobalamin repletionRestores B12-dependent methionine synthase, lowering homocysteine and supporting myelin.
- NAD+ supplyRaises NAD+ available for mitochondrial redox reactions and sirtuin/PARP enzymes.
- Mitochondrial energy supportImproved oxidative phosphorylation capacity in energy-demanding neurons (theoretical in humans).
- Rg3 or peptide neuromodulationGinsenoside Rg3 reduces neuroinflammation in animals; Selank-type peptides modulate GABA and BDNF.
- Integrated neural supportCombined effects aim at energy, mood and cognitive clarity.
- Corrects B12 deficiency
- Subjective energy and clarity
- Unproven cognitive benefit
Researched for
- Cognitive fatigue
- Low energy and mood
- Vitamin B12 deficiency and neuropathy
- Healthy-aging protocols
Research notes
- Vitamin B12 treatment improves neurologic and cognitive symptoms only when a true deficiency exists.
- IV NAD+ raises blood NAD+ levels, but controlled outcome trials for cognition or fatigue are lacking.
- Ginsenoside Rg3 shows neuroprotective and anti-amyloid effects in rodents; human cognitive data are minimal.
- No study has evaluated this three-part combination; product identity of 'RG3' varies.
Reported side effects
- Flushing, chest tightness or nausea with rapid NAD+ infusion
- Injection-site pain (IM B12)
- Headache or dizziness
- Rare acne or rash with high-dose B12
Contraindications & cautions
- Leber's hereditary optic neuropathy or cobalt/cobalamin allergy (B12)
- Unclear product identity ('RG3' not verified)
- Pregnancy and breastfeeding
- Unstable cardiovascular disease (NAD+ infusion)
Lab monitoring
- CBC with MCV
- Vitamin B12, methylmalonic acid, homocysteine
- Folate, iron panel
- CMP
- Blood pressure and heart rate before each infusion
Dosing and pricing for RG3 + Methylcobalamin + NAD+
Dosing references and compound pricing are available to established patients in the secure portal after a medical evaluation.
Ready to take control of your health?
Start with a 60-minute physician evaluation, virtually in seven states or in person in Reston, Virginia.
Cash-pay. HSA and FSA accepted. Monday–Friday, 10 AM – 2 PM (virtual and in person).